C4 Therapeutics, Inc.
- CCCC
- NASDAQ
- Biotechnology
- Targeted Protein Degradation
- Oncology Biotech
$2.77
Today −0.54%Quote Oct 16, 2026, 08:00 PM UTC
−19.01%over the last month
Max drawdown −23.7%From 1-month high −19.0%3 months −22.6%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$340.2M
Quote Oct 16
Next earnings
Nov 5
Expected, not confirmed
Analyst target
$11.33
+309.8% from here
Floor
$2.69
2.7% below price
Where the price sits
14 analysts
Analyst range, low to high
$6.00$20.00
- Price $2.77
- Resistance $2.86
- Consensus $11.33
Analysts' average target sits about 310% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about CCCCPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
104